Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextTrip, Inc. Declaration of Voting Results & Voting Rights Announcements 2021

Jul 16, 2021

34837_rns_2021-07-16_a1577cf2-4675-462a-bf8e-91c09e08d752.zip

Declaration of Voting Results & Voting Rights Announcements

Open in viewer

Opens in your device viewer

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 15, 2021

SIGMA LABS, INC.

(Exact name of registrant as specified in its charter)

Nevada 001-38015 27-1865814
(State
or other jurisdiction of incorporation
or organization) (Commission File
Number) (I.R.S.
Employer Identification
No.)

3900 Paseo del Sol

Santa Fe , New Mexico 87507

Field: Rule-Page

Field: /Rule-Page

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (505) 438-2576

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock, par value $0.001 per share | SGLB | The
NASDAQ Stock Market LLC |
| Warrants
to Purchase Common Stock, par value $0.001 per share | SGLBW | The
NASDAQ Stock Market LLC |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1; Options: NewSection

Field: /Page

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the Annual Meeting of Stockholders of Sigma Labs, Inc. (“we,” “our,” “us,” or the “Company”) held on July 15, 2021 (the “2021 Annual Meeting”), the Company’s stockholders approved an amendment to the Company’s 2013 Equity Incentive Plan (as amended, the “2013 Plan”) to fix at 1,765,000 shares the aggregate number of shares of the Company’s common stock issued or issuable under the 2013 Plan. The Company’s stockholders also approved the Sigma Labs, Inc. 2021 Employee Stock Purchase Plan (the “ESPP”). The amendment to the 2013 Plan and the ESPP were previously approved by the Company’s Board of Directors. A summary of the 2013 Plan and the ESPP is set forth in the Company’s definitive Proxy Statement filed with the Securities and Exchange Commission on June 15, 2021 (the “2021 Proxy Statement”). The summary of each of the 2013 Plan and the ESPP contained in the 2021 Proxy Statement is qualified in its entirety by reference to the full text of the 2013 Plan and the ESPP, a copy of which is filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

As described above in Item 5.02, the 2021 Annual Meeting was held on July 15, 2021. Our stockholders acted upon the following proposals at the 2021 Annual Meeting:

| ● | Proposal
1 : To elect each of John Rice and Mark Ruport as a Class I director until the 2024 Annual Meeting of Stockholders; |
| --- | --- |
| ● | Proposal
2: To approve an amendment to our 2013 Plan to fix at 1,765,000 shares the aggregate number of shares of our common stock issued
or issuable under the 2013 Plan; |
| ● | Proposal
3: To approve the Sigma Labs, Inc. 2021 Employee Stock Purchase Plan; |
| ● | Proposal
4 : To approve, by non-binding vote, the compensation of our named executive officers as disclosed in the 2021 Proxy Statement;
and |
| ● | Proposal
5 : To ratify the selection of Haynie & Company as our independent registered public accounting firm for the fiscal year ending
December 31, 2021. |

Voting Results

Proposal 1 : Mr. Rice was elected as a Class I director with 2,959,303 “FOR” votes, 222,105 “AGAINST” votes and 28,595 “ABSTAIN” votes. Mr. Ruport was elected as a Class I director with 3,029,922 “FOR” votes, 154,779 “AGAINST” votes and 25,302 “ABSTAIN” votes. There were 2,789,587 broker non-votes in connection with this proposal.

Proposal 2 : This proposal was approved with 2,809,282 “FOR” votes, 367,560 “AGAINST” votes and 33,161 “ABSTAIN” votes. There were 2,789,587 broker non-votes in connection with this proposal.

Field: Page; Sequence: 2

Field: /Page

Proposal 3 : This proposal was approved with 3,065,661 “FOR” votes, 120,399 “AGAINST” votes and 23,943 “ABSTAIN” votes. There were 2,789,587 broker non-votes in connection with this proposal.

Proposal 4 : This proposal was approved with 3,041,933 “FOR” votes, 153,502 “AGAINST” votes and 14,568 “ABSTAIN” votes. There were 2,789,587 broker non-votes in connection with this proposal.

Proposal 5 : This proposal was approved with 5,680,690 “FOR” votes, 22,612 “AGAINST” votes and 296,288 “ABSTAIN” votes. There were no broker non-votes in connection with this proposal.

Item 9.01 Financial Statements and Exhibits.

| Exhibit
No . | Description |
| --- | --- |
| 10.1 | Sigma Labs, Inc. 2013 Equity Incentive Plan, as Amended. |
| 10.2 | Sigma Labs, Inc. 2021 Employee Stock Purchase Plan |
| 104 | Cover
Page Interactive Data File (embedded within the Inline XBRL document) |

Field: Page; Sequence: 3

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date:
July 16, 2021 | |
| --- | --- |
| By: | /s/
Mark K. Ruport |
| Name: | Mark
K. Ruport |
| Title: | President
and Chief Executive Officer |

Field: Page; Sequence: 4; Options: Last

Field: /Page